The global in vitro fertilization market size is expected to reach USD 33.9 billion by 2028, expanding at a CAGR of 6.5% over the forecast period, according to a new report by Grand View Research, Inc. The market is driven by the continuous efforts of the market players, government initiatives for better reimbursement policies, and an increase in the incidence of infertility due to lifestyle changes. Expansion of fertility procedures, such as ICSI for treating infertility, is expected to positively impact the market growth in the near future.
Moreover, the availability of genomic testing facilities that enable the prevention of the transfer of genetic disorders during in vitro fertilization (IVF) is further expected to drive the market. The insurance companies are providing coverage to IVF procedures owing to an increase in the number of IVF treatments. This has led to competitive pricing and has moderated the IVF treatment costs as the procedure has been a successfully practiced technology, driving the market with more treatment automation and standardization.
A decline in the Total Fertility Rate (TFR) is a result of factors, such as a behavioral shift in society, a shift from rural to urban societies, increased age of first-time mothers or the age at which women give birth to their first child, an increasing number of women in the labor force, postponement of marriage, and lower marriage rates.
The in-person fertility treatments in the U.S. and Canada were suspended in March 2020 by the Canadian Fertility and Andrology Society and the American Society of Reproductive Medicine due to the COVID-19 pandemic. However, treatments are resuming in many countries with the ease of restrictions, including the developing nations. For instance, in July 2020, Medicover Fertility, an IVF center in India, announced to resume the IVF procedures after the initial COVID-19 risk assessment.
Browse full report with Table of Content @ https://www.grandviewresearch.com/industry-analysis/in-vitro-fertilization-market
In Vitro Fertilization Market Report Highlights
- Culture media dominated the IVF market in 2020 accounting for the maximum revenue share. Several research activities are being undertaken to improve the efficiency of culture media
- For instance, Vitrolife showcased its research on SpermFreeze solution at the American Society for Reproductive Medicine (ASRM) that established the effectiveness of its solution for sperm recovery & sperm-hyaluronic acid-binding
- Europe dominated the global market with the highest revenue share in 2020 due to the availability of affordable treatments, adherence to medical standards, and quick adoption of advanced technologies, such as time-lapse microscopy by the clinics in the region
- The APAC region is expected to witness an increased demand for IVF owing to fertility tourism and the availability of funding for the treatment. In Japan, eligible couples can apply for co-funding for a maximum of three cycles with USD 1,920 for each cycle
- The developing countries in the APAC region are undertaking legal reforms to promote treatment adoption in the region. For instance, in February 2020, the Government of India approved a bill for the regulation of clinics offering reproduction assistance services, including IVF, artificial insemination, and surrogacy
- In January 2020, Merck received Marketing Authorization (MA) from the European Commission (EC) for its recombinant human follicle-stimulating hormone, GONAL-f (follitropin alfa) 150 IU pen
For Requesting a Sample Copy of This Report, Please Visit @ https://www.grandviewresearch.com/industry-analysis/in-vitro-fertilization-market/request/rs1
In Vitro Fertilization Market Segmentation
Grand View Research has segmented the global in vitro fertilization market on the basis of type, end use, instrument, and region:
IVF Type Outlook (Revenue, USD Million, 2016 – 2028)
- Fresh Non-donor
- Frozen Non-donor
- Fresh Donor
- Frozen Donor
IVF End-use Outlook (Revenue, USD Million, 2016 – 2028)
- Fertility Clinics
- Hospitals & Others Settings
IVF Instrument Outlook (Revenue, USD Million, 2016 – 2028)
- Culture Media
- Disposable Devices
- Capital Equipment
IVF Regional Outlook (Revenue, USD Million, 2016 – 2028)
- North America
- U.S.
- Canada
- Europe
- France
- Germany
- Italy
- Spain
- U.K.
- Belgium
- The Netherlands
- Switzerland
- Asia Pacific
- Japan
- China
- India
- Latin America
- Brazil
- Mexico
- Middle East & Africa (MEA)
- South Africa
List of Key Players of In Vitro Fertilization Market
- OvaScience
- EMD Serono, Inc.
- Vitrolife AB
- Irvine Scientific
- Cook Medical, Inc.
- Cooper Surgical, Inc.
- Genea Biomedx
- Thermo Fisher Scientific, Inc.
- Progyny, Inc.
- Boston IVF
Inquire more or share questions if any before the purchase on this report @ https://www.grandviewresearch.com/inquiry/1038/ibb
Browse More Related Report:
In-vitro Fertilization Microscopes Market Size, Share & Trends Analysis Report By End-use (Clinical, Academic Research), By Region (North America, Europe, APAC, LATAM), And Segment Forecasts, 2020 – 2027
About Grand View Research
Grand View Research is a full-time market research and consulting company registered in San Francisco, California. The company fully offers market reports, both customized and syndicates, based on intense data analysis. It also offers consulting services to business communities and academic institutions and helps them understand the global and business scenario to a significant extent. The company operates across multitude of domains such as Chemicals, Materials, Food and Beverages, Consumer Goods, Healthcare, and Information Technology to offer consulting services.
Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1888202951
Address:Grand View Research, Inc. 201 Spear Street 1100 San Francisco, CA 94105, United States
City: San Francisco
State: California
Country: United States
Website: https://www.grandviewresearch.com/industry-analysis/in-vitro-fertilization-market